Field cancerization in the colon: A role for aberrant DNA methylation?

Gastroenterology Report

Volumn 2, Issue 1, 2014, Pages 16-20

  Luo, Yanxin ^a,b   Yu, Ming ^b   Grady, William M ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; DNA methylation; Epigenetic alterations; Field cancerization

Indexed keywords

EID: 84904393925     PISSN: None     EISSN: 20520034     Source Type: Journal    
DOI: 10.1093/gastro/got039     Document Type: Review

References (44)

1. Markowitz SD and Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009;361: 2449-60.
2. Grady WM and Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008;135: 1079-99.
3. Graham TA, McDonald SA and Wright NA. Field cancerization in the GI tract. Future Oncol 2011;7:981-93.
4. Slaughter DP, Southwick HW and Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-68.
5. Bernstein C, Bernstein H, Payne CM et al. Field defects in progression to gastrointestinal tract cancers. Cancer Lett 2008;260:1-10.
6. Van Assche G, Dignass A, Bokemeyer B et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7: 1-33.
7. Okayasu I. Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence. Pathol Int 2012;62:368-80.
8. Azer SA. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. Eur J Gastroenterol Hepatol 2013;25:271-81.
9. Galandiuk S, Rodriguez-Justo M, Jeffery R et al. Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis. Gastroenterology 2012;142:855-864, e8.
10. Levi F, Randimbison L, Blanc-Moya R et al. High constant incidence of second primary colorectal cancer. Int J Cancer 2013;132:1679-82.
11. Hawthorn L, Lan L and Mojica W. Evidence for field effect cancerization in colorectal cancer. Genomics 2013 Dec 3. [Epub ahead of print].
12. Lao VV and Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011;8:686-700.
13. Worthley DL, Whitehall VL, Buttenshaw RL et al. DNA methylation within the normal colorectal mucosa is associated with pathwayspecific predisposition to cancer. Oncogene 2010;29:1653-62.
14. Bird A. The essentials of DNA methylation. Cell 1992;70:5-8.
15. Veigl M, Kasturi L, Olechnowicz J et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Nat Acad Sci USA 1998;95:8698-702.
16. Graff JR, Gabrielson E, Fujii H et al. Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000;275:2727-32.
17. Jubb AM, Bell SM and Quirke P. Methylation and colorectal cancer. J Pathol 2001;195:111-34.
18. Kim YH, Petko Z, Dzieciatkowski S et al. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 2006;45:781-89.
19. Shen L, Kondo Y, Rosner GL et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005;97:1330-38.
20. Ahuja N, Li Q, Mohan M et al. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;58:5489-94.
21. Maekita T, Nakazawa K, Mihara M et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006;12:989-95.
22. Rashid A, Shen L, Morris JS et al. CpG island methylation in colorectal adenomas. Am J Pathol 2001;159:1129-35.
23. Braakhuis BJ, Tabor MP, Kummer JA et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
24. Hiraoka S, Kato J, Horii J et al. Methylation status of normal background mucosa is correlated with occurrence and development of neoplasia in the distal colon. Hum Pathol 41:38-47.
25. Kawakami K, Ruszkiewicz A, Bennett G et al. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer 2006;94:593-98.
26. Belshaw NJ, Pal N, Tapp HS et al. Patterns of DNA methylation in individual colonic crypts reveal aging and cancer-related field defects in the morphologically normal mucosa. Carcinogenesis 2010;31:1158-63.
27. Shen L, Kondo Y, Hamilton SR et al. P14 methylation in human colon cancer is associated with microsatellite instability and wildtype p53. Gastroenterology 2003;124:626-33.
28. Grady WM, Parkin RK, Mitchell PS et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008;27:3880-88.
29. Belshaw NJ, Elliott GO, Foxall RJ et al. Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa. Br J Cancer 2008;99:136-42.
30. Paun BC, Kukuruga D, Jin Z et al. Relation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas. Cancer 2010;116:4495-501.
31. Kamiyama H, Suzuki K, Maeda T et al. DNA demethylation in normal colon tissue predicts predisposition to multiple cancers. Oncogene 2012;31:5029-37.
32. Xu G, Bestor T, Bourc'his D et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNa methylatransferase gene. Nature 1999;402:187-89.
33. Figueiredo JC, Grau MV, Wallace K et al. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009;18:1041-49.
34. Wallace K, Grau MV, Levine AJ et al. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila) 2010;3:1552-64.
35. Guo M, House MG, Hooker C et al. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res 2004;10:5131-36.
36. Yan PS, Venkataramu C, Ibrahim A et al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 2006;12:6626-36.
37. Eads CA, Lord RV, Kurumboor SK et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000;60:5021-26.
38. Nakajima T, Maekita T, Oda I et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev 2006;15:2317-21.
39. Chiba T, Marusawa H and Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012; 143:550-63.
40. Vogelstein B and Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99.
41. Gerlinger M, Rowan AJ, Horswell S et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883-92.
42. Baker AM, Graham TA and Wright NA. Pre-tumour clones, periodic selection and clonal interference in the origin and progression of gastrointestinal cancer: potential for biomarker development. J Pathol 2013;229:502-14.
43. Williams EA, Welfare M, Spiers A et al. Systemic folate status, rectal mucosal folate concentration and dietary intake in patients at differential risk of bowel cancer (The FAB2 Study). Eur J Nutr 2013;52: 1801-10.
44. Charles MA, Johnson IT and Belshaw NJ. Supra-physiological folic acid concentrations induce aberrant DNA methylation in normal human cells in vitro. Epigenetics 2012;7:689-94.